XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Additional paid-in capital
Treasury shares
Own shares held by ESOP
Retained earnings
Accumulated other comprehensive loss
Ordinary shares
Common stock
Deferred shares
Common stock
Beginning balance at Dec. 31, 2019 $ 174.4 $ 68.4 $ (4.0) $ (1.7) $ 84.8 $ (149.6) $ 26.6 $ 149.9
Beginning balance (in shares) at Dec. 31, 2019     (400,000) (1,200,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 6.2       6.2      
Shares sold from ESOP 0.0              
Other comprehensive income (loss), net of tax (7.3)         (7.3)    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.5 0.5            
Utilization of treasury shares to satisfy share based compensation (0.6) (0.7)   $ 0.1        
Utilization of treasury shares to satisfy share based compensation (in shares)       100,000        
Ending balance at Mar. 29, 2020 169.8 68.2 $ (4.0) $ (1.6) 87.6 (156.9) 26.6 149.9
Ending balance (in shares) at Mar. 29, 2020     (400,000) (1,100,000)        
Beginning balance at Dec. 31, 2019 174.4 68.4 $ (4.0) $ (1.7) 84.8 (149.6) 26.6 149.9
Beginning balance (in shares) at Dec. 31, 2019     (400,000) (1,200,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 12.9              
Other comprehensive income (loss), net of tax (2.3)              
Ending balance at Sep. 27, 2020 176.7 70.1 $ (4.0) $ (1.5) 87.5 (151.9) 26.6 149.9
Ending balance (in shares) at Sep. 27, 2020     (400,000) (1,000,000.0)        
Beginning balance at Mar. 29, 2020 169.8 68.2 $ (4.0) $ (1.6) 87.6 (156.9) 26.6 149.9
Beginning balance (in shares) at Mar. 29, 2020     (400,000) (1,100,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 4.1       4.1      
Shares sold from ESOP 0.9 0.9            
Other comprehensive income (loss), net of tax 1.5         1.5    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.8 0.8            
Utilization of shares from ESOP to satisfy share based compensation (0.4) (0.5)   $ 0.1        
Utilization of shares from ESOP to satisfy share based compensation (in shares)       100,000        
Ending balance at Jun. 28, 2020 173.3 69.4 $ (4.0) $ (1.5) 88.3 (155.4) 26.6 149.9
Ending balance (in shares) at Jun. 28, 2020     (400,000) (1,000,000.0)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 2.6       2.6      
Other comprehensive income (loss), net of tax 3.5         3.5    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.8 0.8            
Utilization of shares from ESOP to satisfy share based compensation (0.1) (0.1)            
Ending balance at Sep. 27, 2020 176.7 70.1 $ (4.0) $ (1.5) 87.5 (151.9) 26.6 149.9
Ending balance (in shares) at Sep. 27, 2020     (400,000) (1,000,000.0)        
Beginning balance at Dec. 31, 2020 167.1 70.6 $ (4.0) $ (1.4) 91.2 (165.8) 26.6 149.9
Beginning balance (in shares) at Dec. 31, 2020     (400,000) (1,000,000.0)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 14.5       14.5      
Other comprehensive income (loss), net of tax 1.5         1.5    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.5 0.5            
Utilization of shares from ESOP to satisfy share based compensation (1.3) (1.4)   $ 0.1        
Utilization of shares from ESOP to satisfy share based compensation (in shares)       100,000        
Ending balance at Mar. 28, 2021 178.9 69.7 $ (4.0) $ (1.3) 102.3 (164.3) 26.6 149.9
Ending balance (in shares) at Mar. 28, 2021     (400,000) (900,000)        
Beginning balance at Dec. 31, 2020 167.1 70.6 $ (4.0) $ (1.4) 91.2 (165.8) 26.6 149.9
Beginning balance (in shares) at Dec. 31, 2020     (400,000) (1,000,000.0)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 30.3              
Other comprehensive income (loss), net of tax $ 2.0              
Purchase of own shares (in shares) (126,734)              
Purchase of own shares $ (2.8)              
Ending balance at Sep. 26, 2021 186.7 69.5 $ (5.5) $ (1.2) 111.3 (163.8) 26.5 149.9
Ending balance (in shares) at Sep. 26, 2021     (500,000) (800,000)        
Beginning balance at Mar. 28, 2021 178.9 69.7 $ (4.0) $ (1.3) 102.3 (164.3) 26.6 149.9
Beginning balance (in shares) at Mar. 28, 2021     (400,000) (900,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 11.0       11.0      
Other comprehensive income (loss), net of tax 1.9         1.9    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.9 0.9            
Utilization of shares from ESOP to satisfy share based compensation (0.2) (0.3)   $ 0.1        
Utilization of shares from ESOP to satisfy share based compensation (in shares)       100,000        
Cancellation of ordinary share capital (0.9) (0.8)         (0.1)  
Ending balance at Jun. 27, 2021 188.2 69.5 $ (4.0) $ (1.2) 109.9 (162.4) 26.5 149.9
Ending balance (in shares) at Jun. 27, 2021     (400,000) (800,000)        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 4.8       4.8      
Shares sold from ESOP (0.1) (0.1)            
Other comprehensive income (loss), net of tax (1.4)         (1.4)    
Dividends declared (3.4)       (3.4)      
Share-based compensation 0.8 0.8            
Utilization of shares from ESOP to satisfy share based compensation $ (0.3) (0.3)            
Purchase of own shares (in shares) (88,734)   (100,000)          
Purchase of own shares $ (1.5)   $ (1.5)          
Cancellation of ordinary share capital (0.4) (0.4)            
Ending balance at Sep. 26, 2021 $ 186.7 $ 69.5 $ (5.5) $ (1.2) $ 111.3 $ (163.8) $ 26.5 $ 149.9
Ending balance (in shares) at Sep. 26, 2021     (500,000) (800,000)